肝衰竭患者脓毒症的病原菌特征及危险因素分析
该回顾性研究纳入2014年1月至2018年12月天津市第二人民医院收治的194例肝衰竭患者,按是否合并脓毒症分为脓毒症组52例和非脓毒症组142例,比较两组血培养病原菌分布及白细胞、中性粒细胞、血小板、乳酸、C反应蛋白和降钙素原水平,并用多因素Logistic回归分析脓毒症的危险因素。结果显示2014至2018年脓毒症阳性病例分别为11、12、11、11和8例,其中G+菌逐年增加(分别为2、3、4、5和4例)。脓毒症组中性粒细胞、乳酸、C反应蛋白和降钙素原均显著高于非脓毒症组,多因素分析显示乳酸是肝衰竭患者发生脓毒症的独立危险因素(OR=58.286,95%CI 16.633-204.247,P=0.000)。
要点
- 肝衰竭合并脓毒症患者血培养G+菌阳性例数逐年增加,2014至2018年分别为2、3、4、5和4例。
- 脓毒症组乳酸显著高于非脓毒症组(3.04±0.61 mmol/L vs. 2.00±0.43 mmol/L,P<0.05)。
- 多因素Logistic回归显示乳酸升高是肝衰竭患者脓毒症的独立危险因素(OR=58.286,95%CI 16.633-204.247,P=0.000)。
- 脓毒症组中性粒细胞、C反应蛋白和降钙素原均显著高于非脓毒症组(均P<0.05),而白细胞和血小板两组无统计学差异。
适用人群与场景
- 2014年1月至2018年12月天津市第二人民医院收治的肝衰竭患者,最终纳入194例进行分析。
- 排除数据不完整的27例患者。
研究设计与关键结果
- 研究类型为回顾性研究,纳入194例肝衰竭患者,其中脓毒症组52例、非脓毒症组142例。
- 2014至2018年肝衰竭患者脓毒症阳性病例分别为11、12、11、11和8例;G+菌阳性例数分别为2、3、4、5和4例。
- 脓毒症组与非脓毒症组比较:中性粒细胞0.81±0.09 vs. 0.74±0.15,乳酸3.04±0.61 mmol/L vs. 2.00±0.43 mmol/L,C反应蛋白44.09±8.37 mg/L vs. 40.54±8.37 mg/L,降钙素原0.34±0.12 μg/L vs. 0.31±0.11 μg/L,差异均有统计学意义(均P<0.05)。
- 两组白细胞和血小板差异无统计学意义。
- 多因素Logistic回归显示乳酸是肝衰竭患者脓毒症的独立危险因素(OR=58.286,95%CI 16.633-204.247,P=0.000)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于肝衰竭感染患者,G+菌比例逐年增加。
- 作者认为,乳酸升高是肝衰竭患者脓毒症的独立危险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the pathogenic characteristics of sepsis in patients with hepatic failure, and to explore the risk factors for sepsis in patients with liver failure.
METHODS: The data of 221 patients with hepatic failure admitted to Tianjin Second People's Hospital from January 2014 to December 2018 were retrospectively collected. The patients were divided into two groups according to whether they suffered from sepsis or not. The pathogeny results of blood culture in patients with sepsis were observed. The levels of white blood cell (WBC), neutrophil (Neut), platelet (PLT), lactic acid (Lac), C-reactive protein (CRP) and procalcitonin (PCT) were compared between the two groups. The risk factors for sepsis in patients with hepatic failure were analyzed by multivariate Logistic regression analysis.
RESULTS: Among 221 patients, 27 cases had incomplete data and were excluded. Finally, 194 cases were enrolled in the analysis, including 52 in sepsis group and 142 in non-sepsis group. From 2014 to 2018, there were 11, 12, 11, 11 and 8 positive cases of sepsis in patients with liver failure. The positive rate of Gram-positive (G+) bacteria increased year by year (2, 3, 4, 5 and 4 cases of G+ bacteria from 2014 to 2018). There was no significant difference in demographic and medical history data, such as gender, age and history of diabetes mellitus between the two groups. Compared with non-sepsis group, Neut, Lac, CRP and PCT in sepsis group were significantly increased [Neut: 0.81±0.09 vs. 0.74±0.15, Lac (mmol/L): 3.04±0.61 vs. 2.00±0.43, CRP (mg/L): 44.09±8.37 vs. 40.54±8.37, PCT (μg/L): 0.34±0.12 vs. 0.31±0.11], with significant differences (all P < 0.05). But there was no statistical difference in WBC or PLT between the two groups. The multivariate Logistic regression model incorporated the indicators with statistical significance in univariate analysis. The results showed that Lac was an independent factor of sepsis in patients with hepatic failure [odds ratio (OR) = 58.286, 95% confidence interval (95%CI) = 16.633-204.247, P = 0.000].
CONCLUSIONS: For patients with hepatic failure infection, the ratio of G+ bacteria increased year by year. Elevated Lac is an independent risk factor for sepsis in patients with liver failure.
参考来源
- Qian J, Liu G, Wang R, et al. [Risk factors for sepsis in patients with hepatic failure]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31441418. doi:10.3760/cma.j.issn.2095-4352.2019.07.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。